Loading…
Immunological abnormalities in myelodysplastic syndromes. Prospective study (series of 40 patients)
The association of myelodysplastic syndromes (MDS) with auto-immune diseases and humoral disorders have already been reported. In this prospective study we tried to estimate type and the frequency of immunological associated diseases among patients affected by MDS. In this prospective study, auto-im...
Saved in:
Published in: | La revue de medecine interne 2005-10, Vol.26 (10), p.777-783 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | fre |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 783 |
container_issue | 10 |
container_start_page | 777 |
container_title | La revue de medecine interne |
container_volume | 26 |
creator | Bouali, F Berrah, A Si Ahmed-Bouali, D Harrieche, F Benhalima, M Hamladji, R M Arrada, M |
description | The association of myelodysplastic syndromes (MDS) with auto-immune diseases and humoral disorders have already been reported. In this prospective study we tried to estimate type and the frequency of immunological associated diseases among patients affected by MDS.
In this prospective study, auto-immune disease and humoral immunity disorders were systematically searched during MDS and conversely MDS searched during cytopenia. All MDS secondary to chemotherapy and the children's MDS were excluded. The MDS diagnosis was established according to FAB criteria and patients were classified in two groups A or B according to presence (group A) or not (group B) of dysimmune manifestations.
Forty patients(19 males and 21 females, mean age of 56,6 years) with MDS have been enrolled during this period (group A: 20 patients). Associated diseases are following: systemic lupus erythematosus (three), lupus-like syndrome(one), sarcoidisis(one), Sjogrën syndrome(one), polyarthritis (two), chronic liver diseases (three), autoimmune thyroid diseases (two), pyoderma gangrenosum (one), Crohn's disease(one), haemolytic anaemia (one), and pericardial effusion(one).
A wide spectrum of auto-immune manifestations is frequently reported in myelodysplastic syndromes. Further studies are necessary for discuss the current physiopathological hypothesis with their therapeutic relevance. |
doi_str_mv | 10.1016/j.revmed.2005.06.012 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_68697880</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68697880</sourcerecordid><originalsourceid>FETCH-LOGICAL-p139t-791ae10c837a17f4b71eb75afc34d3f6bdc0632032c26a28c91dfe2b0ce692403</originalsourceid><addsrcrecordid>eNo1kD1PwzAURT2AaCn8A4Q8IRgSnu3USUZU8VGpEgwwR47zglzZcbCTSvn3pKJMdzn36OoScsMgZcDk4z4NeHDYpBxgnYJMgfEzsgSeFUkhpViQyxj3ADDT5QVZMMlBwHq9JHrr3Nh567-NVpaquvPBKWsGg5GajroJrW-m2FsVB6NpnLomeIcxpR_Bxx71YA5I4zA2E72PGI4939IMaK9mSTfEhyty3iob8fqUK_L18vy5eUt276_bzdMu6ZkohyQvmUIGuhC5Ynmb1TnDOl-rVousEa2sGw1SzMO55lLxQpesaZHXoFGWPAOxInd_3j74nxHjUDkTNVqrOvRjrGQhy7wojuDtCRzr-bWqD8apMFX_t4hfndFmSg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68697880</pqid></control><display><type>article</type><title>Immunological abnormalities in myelodysplastic syndromes. Prospective study (series of 40 patients)</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Bouali, F ; Berrah, A ; Si Ahmed-Bouali, D ; Harrieche, F ; Benhalima, M ; Hamladji, R M ; Arrada, M</creator><creatorcontrib>Bouali, F ; Berrah, A ; Si Ahmed-Bouali, D ; Harrieche, F ; Benhalima, M ; Hamladji, R M ; Arrada, M</creatorcontrib><description>The association of myelodysplastic syndromes (MDS) with auto-immune diseases and humoral disorders have already been reported. In this prospective study we tried to estimate type and the frequency of immunological associated diseases among patients affected by MDS.
In this prospective study, auto-immune disease and humoral immunity disorders were systematically searched during MDS and conversely MDS searched during cytopenia. All MDS secondary to chemotherapy and the children's MDS were excluded. The MDS diagnosis was established according to FAB criteria and patients were classified in two groups A or B according to presence (group A) or not (group B) of dysimmune manifestations.
Forty patients(19 males and 21 females, mean age of 56,6 years) with MDS have been enrolled during this period (group A: 20 patients). Associated diseases are following: systemic lupus erythematosus (three), lupus-like syndrome(one), sarcoidisis(one), Sjogrën syndrome(one), polyarthritis (two), chronic liver diseases (three), autoimmune thyroid diseases (two), pyoderma gangrenosum (one), Crohn's disease(one), haemolytic anaemia (one), and pericardial effusion(one).
A wide spectrum of auto-immune manifestations is frequently reported in myelodysplastic syndromes. Further studies are necessary for discuss the current physiopathological hypothesis with their therapeutic relevance.</description><identifier>ISSN: 0248-8663</identifier><identifier>DOI: 10.1016/j.revmed.2005.06.012</identifier><identifier>PMID: 16203055</identifier><language>fre</language><publisher>France</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Anemia, Hemolytic - complications ; Arthritis - complications ; Autoimmune Diseases - complications ; Chronic Disease ; Crohn Disease - complications ; Female ; Humans ; Liver Diseases - complications ; Lupus Erythematosus, Systemic - complications ; Male ; Middle Aged ; Myelodysplastic Syndromes - complications ; Myelodysplastic Syndromes - immunology ; Myelodysplastic Syndromes - mortality ; Pericardial Effusion - complications ; Prospective Studies ; Pyoderma Gangrenosum - complications ; Sarcoidosis - complications ; Sjogren's Syndrome - complications ; Thyroid Diseases - complications</subject><ispartof>La revue de medecine interne, 2005-10, Vol.26 (10), p.777-783</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16203055$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bouali, F</creatorcontrib><creatorcontrib>Berrah, A</creatorcontrib><creatorcontrib>Si Ahmed-Bouali, D</creatorcontrib><creatorcontrib>Harrieche, F</creatorcontrib><creatorcontrib>Benhalima, M</creatorcontrib><creatorcontrib>Hamladji, R M</creatorcontrib><creatorcontrib>Arrada, M</creatorcontrib><title>Immunological abnormalities in myelodysplastic syndromes. Prospective study (series of 40 patients)</title><title>La revue de medecine interne</title><addtitle>Rev Med Interne</addtitle><description>The association of myelodysplastic syndromes (MDS) with auto-immune diseases and humoral disorders have already been reported. In this prospective study we tried to estimate type and the frequency of immunological associated diseases among patients affected by MDS.
In this prospective study, auto-immune disease and humoral immunity disorders were systematically searched during MDS and conversely MDS searched during cytopenia. All MDS secondary to chemotherapy and the children's MDS were excluded. The MDS diagnosis was established according to FAB criteria and patients were classified in two groups A or B according to presence (group A) or not (group B) of dysimmune manifestations.
Forty patients(19 males and 21 females, mean age of 56,6 years) with MDS have been enrolled during this period (group A: 20 patients). Associated diseases are following: systemic lupus erythematosus (three), lupus-like syndrome(one), sarcoidisis(one), Sjogrën syndrome(one), polyarthritis (two), chronic liver diseases (three), autoimmune thyroid diseases (two), pyoderma gangrenosum (one), Crohn's disease(one), haemolytic anaemia (one), and pericardial effusion(one).
A wide spectrum of auto-immune manifestations is frequently reported in myelodysplastic syndromes. Further studies are necessary for discuss the current physiopathological hypothesis with their therapeutic relevance.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Anemia, Hemolytic - complications</subject><subject>Arthritis - complications</subject><subject>Autoimmune Diseases - complications</subject><subject>Chronic Disease</subject><subject>Crohn Disease - complications</subject><subject>Female</subject><subject>Humans</subject><subject>Liver Diseases - complications</subject><subject>Lupus Erythematosus, Systemic - complications</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Myelodysplastic Syndromes - complications</subject><subject>Myelodysplastic Syndromes - immunology</subject><subject>Myelodysplastic Syndromes - mortality</subject><subject>Pericardial Effusion - complications</subject><subject>Prospective Studies</subject><subject>Pyoderma Gangrenosum - complications</subject><subject>Sarcoidosis - complications</subject><subject>Sjogren's Syndrome - complications</subject><subject>Thyroid Diseases - complications</subject><issn>0248-8663</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNo1kD1PwzAURT2AaCn8A4Q8IRgSnu3USUZU8VGpEgwwR47zglzZcbCTSvn3pKJMdzn36OoScsMgZcDk4z4NeHDYpBxgnYJMgfEzsgSeFUkhpViQyxj3ADDT5QVZMMlBwHq9JHrr3Nh567-NVpaquvPBKWsGg5GajroJrW-m2FsVB6NpnLomeIcxpR_Bxx71YA5I4zA2E72PGI4939IMaK9mSTfEhyty3iob8fqUK_L18vy5eUt276_bzdMu6ZkohyQvmUIGuhC5Ynmb1TnDOl-rVousEa2sGw1SzMO55lLxQpesaZHXoFGWPAOxInd_3j74nxHjUDkTNVqrOvRjrGQhy7wojuDtCRzr-bWqD8apMFX_t4hfndFmSg</recordid><startdate>200510</startdate><enddate>200510</enddate><creator>Bouali, F</creator><creator>Berrah, A</creator><creator>Si Ahmed-Bouali, D</creator><creator>Harrieche, F</creator><creator>Benhalima, M</creator><creator>Hamladji, R M</creator><creator>Arrada, M</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>200510</creationdate><title>Immunological abnormalities in myelodysplastic syndromes. Prospective study (series of 40 patients)</title><author>Bouali, F ; Berrah, A ; Si Ahmed-Bouali, D ; Harrieche, F ; Benhalima, M ; Hamladji, R M ; Arrada, M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p139t-791ae10c837a17f4b71eb75afc34d3f6bdc0632032c26a28c91dfe2b0ce692403</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>fre</language><creationdate>2005</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Anemia, Hemolytic - complications</topic><topic>Arthritis - complications</topic><topic>Autoimmune Diseases - complications</topic><topic>Chronic Disease</topic><topic>Crohn Disease - complications</topic><topic>Female</topic><topic>Humans</topic><topic>Liver Diseases - complications</topic><topic>Lupus Erythematosus, Systemic - complications</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Myelodysplastic Syndromes - complications</topic><topic>Myelodysplastic Syndromes - immunology</topic><topic>Myelodysplastic Syndromes - mortality</topic><topic>Pericardial Effusion - complications</topic><topic>Prospective Studies</topic><topic>Pyoderma Gangrenosum - complications</topic><topic>Sarcoidosis - complications</topic><topic>Sjogren's Syndrome - complications</topic><topic>Thyroid Diseases - complications</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bouali, F</creatorcontrib><creatorcontrib>Berrah, A</creatorcontrib><creatorcontrib>Si Ahmed-Bouali, D</creatorcontrib><creatorcontrib>Harrieche, F</creatorcontrib><creatorcontrib>Benhalima, M</creatorcontrib><creatorcontrib>Hamladji, R M</creatorcontrib><creatorcontrib>Arrada, M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>La revue de medecine interne</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bouali, F</au><au>Berrah, A</au><au>Si Ahmed-Bouali, D</au><au>Harrieche, F</au><au>Benhalima, M</au><au>Hamladji, R M</au><au>Arrada, M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immunological abnormalities in myelodysplastic syndromes. Prospective study (series of 40 patients)</atitle><jtitle>La revue de medecine interne</jtitle><addtitle>Rev Med Interne</addtitle><date>2005-10</date><risdate>2005</risdate><volume>26</volume><issue>10</issue><spage>777</spage><epage>783</epage><pages>777-783</pages><issn>0248-8663</issn><abstract>The association of myelodysplastic syndromes (MDS) with auto-immune diseases and humoral disorders have already been reported. In this prospective study we tried to estimate type and the frequency of immunological associated diseases among patients affected by MDS.
In this prospective study, auto-immune disease and humoral immunity disorders were systematically searched during MDS and conversely MDS searched during cytopenia. All MDS secondary to chemotherapy and the children's MDS were excluded. The MDS diagnosis was established according to FAB criteria and patients were classified in two groups A or B according to presence (group A) or not (group B) of dysimmune manifestations.
Forty patients(19 males and 21 females, mean age of 56,6 years) with MDS have been enrolled during this period (group A: 20 patients). Associated diseases are following: systemic lupus erythematosus (three), lupus-like syndrome(one), sarcoidisis(one), Sjogrën syndrome(one), polyarthritis (two), chronic liver diseases (three), autoimmune thyroid diseases (two), pyoderma gangrenosum (one), Crohn's disease(one), haemolytic anaemia (one), and pericardial effusion(one).
A wide spectrum of auto-immune manifestations is frequently reported in myelodysplastic syndromes. Further studies are necessary for discuss the current physiopathological hypothesis with their therapeutic relevance.</abstract><cop>France</cop><pmid>16203055</pmid><doi>10.1016/j.revmed.2005.06.012</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0248-8663 |
ispartof | La revue de medecine interne, 2005-10, Vol.26 (10), p.777-783 |
issn | 0248-8663 |
language | fre |
recordid | cdi_proquest_miscellaneous_68697880 |
source | ScienceDirect Freedom Collection 2022-2024 |
subjects | Adult Aged Aged, 80 and over Anemia, Hemolytic - complications Arthritis - complications Autoimmune Diseases - complications Chronic Disease Crohn Disease - complications Female Humans Liver Diseases - complications Lupus Erythematosus, Systemic - complications Male Middle Aged Myelodysplastic Syndromes - complications Myelodysplastic Syndromes - immunology Myelodysplastic Syndromes - mortality Pericardial Effusion - complications Prospective Studies Pyoderma Gangrenosum - complications Sarcoidosis - complications Sjogren's Syndrome - complications Thyroid Diseases - complications |
title | Immunological abnormalities in myelodysplastic syndromes. Prospective study (series of 40 patients) |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T10%3A21%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immunological%20abnormalities%20in%20myelodysplastic%20syndromes.%20Prospective%20study%20(series%20of%2040%20patients)&rft.jtitle=La%20revue%20de%20medecine%20interne&rft.au=Bouali,%20F&rft.date=2005-10&rft.volume=26&rft.issue=10&rft.spage=777&rft.epage=783&rft.pages=777-783&rft.issn=0248-8663&rft_id=info:doi/10.1016/j.revmed.2005.06.012&rft_dat=%3Cproquest_pubme%3E68697880%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p139t-791ae10c837a17f4b71eb75afc34d3f6bdc0632032c26a28c91dfe2b0ce692403%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=68697880&rft_id=info:pmid/16203055&rfr_iscdi=true |